SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is trending as the market reacts to a landmark joint venture between AT&T, Verizon, and T-Mobile to expand direct-to-device satellite connectivity, fueling speculation that ASTS will serve as the essential infrastructure layer for these major carriers. While the stock experiences high volatility, the community is actively debating the significance of these carrier partnerships and the potential for a major short squeeze as investors look ahead to upcoming satellite launch milestones.

Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company, which focuses on the discovery, acquisition, and development of small molecules and biologics to treat and prevent human disease and alleviate suffering. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and TNX-1800. The company was founded by Seth Lederman and Donald W. Landry on November 16, 2007 and is headquartered in Berkeley Heights, NJ.

Tonix Pharmaceuticals Holding Corp

Tonix Pharmaceuticals is trending as the community actively discusses the stock's recent GPO partnership and potential for commercial traction, while weighing these developments against persistent concerns regarding management's history of dilution and the company's capital burn. Investors are closely monitoring weekly prescription data and upcoming earnings reports, debating whether current commercial progress justifies the stock's valuation or indicates continued financial instability.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candel Therapeutics is trending as investors prepare for pivotal extended Phase 3 data for CAN-2409, with the community closely monitoring the upcoming plenary presentation for evidence of practice-changing efficacy in prostate cancer. Market participants are actively discussing the stock's significant institutional support, potential for a premium buyout by Big Pharma, and the ongoing tension between optimistic long-term holders and aggressive short-selling activity.

Trio-Tech International engages in the provision of third-party semiconductor testing and burn-in services. It operates through the following segments: Semiconductor Back-End Solutions (SBS) and Industrial Electronics. The SBS segment is focused on the sale of burn-in and reliability test equipment used in the back-end manufacturing processes of semiconductors. Its equipment includes burn-in systems, burn-in boards, and related equipment that is used in the testing of structural integrity of integrated circuits. The Industrial Electronics segment consists of designing, manufacturing, and distributing a range of tests, processes, and other equipment used in the manufacturing processes of customers in various industries in the consumer and industrial market. The company was founded in 1958 and is headquartered in Los Angeles, CA.

Trio-Tech International

Trio-Tech International is trending as investors pivot from story-driven AI names to companies with verifiable semiconductor revenue, with many drawing favorable valuation comparisons to industry peers despite its smaller market cap. The community is actively discussing its potential for a re-rating, fueled by expanding AI and EV testing demand and a lean share structure that amplifies volatility.

Venture Global, Inc. engages in the provision of United States liquefied natural gas sourced from resource rich North American natural gas basins. It operates through the following segments: Calcasieu Project, Plaquemines Project, CP2 Project, and Sales and shipping. The company was founded by Michael Sabel and Robert Pender in 2023 and is headquartered in Arlington, VA.

Venture Global Inc. - Ordinary Shares - Class A

Venture Global Inc

Venture Global is trending as investors react to strong earnings and raised EBITDA guidance, while the community actively discusses the stock's significant long-term growth potential and its strategic importance in the ongoing global LNG supply disruption. Traders are closely monitoring the impact of Middle East geopolitical tensions and potential price target upgrades as they anticipate a breakout beyond current resistance levels.

UiPath, Inc. engages in the development and provision of a software platform to automate business processes. The firm serves the public, healthcare, telecommunication, finance, and banking industries. It also offers accounts payable automation, claims processing automation, contact center automation, and finance and accounting automation. The company was founded by Daniel Dines and Marius Tirca in 2005 and is headquartered in New York, NY.

UiPath Inc - Ordinary Shares - Class A

UiPath Inc

UiPath is trending as investors aggressively debate whether the current price represents a deep-value accumulation opportunity or a value trap, with community sentiment split between frustration over persistent share price weakness and conviction in the company's pivot toward agentic AI orchestration. Traders are closely monitoring a high level of short interest and significant institutional accumulation, viewing upcoming earnings as a critical catalyst to potentially break the stock out of its long-standing consolidation phase.

Enphase Energy, Inc. is a global energy technology company, which engages in the business of designing, developing, manufacturing, and selling home energy solutions that manage energy generation, energy storage, control, and communications on one intelligent platform. It operates through the following geographical segments: the United States, the Netherlands, and Others. The company was founded by Raghuveer R. Belur and Martin Fornage in March 2006 and is headquartered in Fremont, CA.

Enphase Energy Inc

Enphase Energy is generating intense market discussion following a strategic pivot into high-density power solutions for AI data centers and a series of product rollouts, including its new solid-state transformer platform. While the solar sector faces ongoing macro headwinds and cyclical demand challenges, the community is actively debating whether these infrastructure-focused innovations will serve as a fundamental re-rating catalyst for the stock.

SolarEdge Technologies, Inc. engages in the development of energy technology, which provides inverter solutions. The firm operates through the following segments: Solar and All Other. The Solar segment includes the design, development, manufacturing, and sales of an inverter solution designed to maximize power generation. The All Other segment includes the design, development, manufacturing and sales of UPS products, energy storage products, e-Mobility products, and automated machines. Its products and services include photovoltaic inverters, power optimizers, photovoltaic monitoring, software tools, and electric vehicle chargers. The company was founded by Guy Sella, Lior Handelsman, Yoav Galin, Meir Adest, and Amir Fishelov on August 7, 2006 and is headquartered in Herzliya, Israel.

Solaredge Technologies Inc

SolarEdge is experiencing significant market interest driven by a strategic shift toward AI data center power infrastructure and energy optimization, alongside a technical short squeeze. Community sentiment is sharply divided, with some investors betting on a long-term turnaround fueled by new product launches and AI demand, while others remain skeptical, citing fundamental challenges and potential volatility.

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Novo Nordisk is capturing significant investor attention following a robust quarterly performance that exceeded revenue and profit expectations, driven by the strong adoption of its oral Wegovy GLP-1 therapy. The community is actively discussing this momentum as a potential reversal of previous growth concerns, while also tracking high-volume prescription data and competitive dynamics against Eli Lilly.

Bitmine Immersion Technologies, Inc. is a technology company focused on acquiring, holding, and actively managing ETH as its primary treasury reserve asset. It prioritizes digital ecosystem services, such as consultancy and advisory works. The company was founded on August 16, 1995 and is headquartered in Las Vegas, NV.

BitMine Immersion Technologies Inc

Bitmine Immersion Technologies Inc

Bitmine Immersion Technologies is facing intense retail scrutiny and bearish sentiment after management announced a pivot to slow down Ethereum accumulation, sparking concerns over dilution and a potential shift in strategy. While institutional investors monitor the stock's tight correlation with ETH, community discussion remains heavily divided between those holding for a long-term crypto turnaround and frustrated traders who are losing confidence in leadership's aggressive growth targets.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Sam Iam

StockTwits for iOS

Coherus Oncology Inc.

BigDaddyCapital

@BigDaddyCapital that sound ominous, but the set up into data is still good right?

hansi koeper

Nick

Toadvine

 that sound ominous, but the set up into data is still good right?

CarmineJr

@whateverhappenedthere if they release it in time… they have major liquidity issues delaying this will create another raise 

No mention of Intas milestones either

 if they release it in time… they have major liquidity issues delaying this will create another raise 

No mention of Intas milestones either

@BigDaddyCapital @whateverhappenedthere I think we find out right after June 30 whether we get the first $37.5 milion earn-out, which is more than we lost last quarter. And I believe we&#39;ll hear about the second earn-out right after Sept. 30. That would add two quarters to our runway right there, and all five data readouts would be out.

StockTwits Web

 I think we find out right after June 30 whether we get the first $37.5 milion earn-out, which is more than we lost last quarter. And I believe we'll hear about the second earn-out right after Sept. 30. That would add two quarters to our runway right there, and all five data readouts would be out.